Skip to main content
main-content

07.01.2016 | Original Article | Ausgabe 7/2016

Tumor Biology 7/2016

Identification of novel NRAGE involved in the radioresistance of esophageal cancer cells

Zeitschrift:
Tumor Biology > Ausgabe 7/2016
Autoren:
Huandi Zhou, Ge Zhang, Xiaoying Xue, Yanling Yang, Ye Yang, Xiaojing Chang, Xiaohui Ge, Zhiqing Xiao, Han Guo, Yanqiang Wang
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1007/​s13277-015-4747-6) contains supplementary material, which is available to authorized users.

Abstract

Radiotherapy (RT) is one main method for the treatment of esophageal squamous cell carcinoma (ESCC), and the radioresistance is the predominant cause of patients with local recurrence. The previous results of gene microarray and subsequent verification showed that NRAGE might be involved in radiation resistance of ESCC cells. In this study, we reestablished human esophageal carcinoma radioresistant cell lines TE13R120 and ECA109R60 with gradient dose irradiation as previously reported, respectively. NRAGE expression was high in TE13R120 and ECA109R60 cells and was correlative with ionizing radiation (IR) resistance in clinic. However, the radiosensitivity of TE13R120 cells had a remarkable increase detected by colony formation assays after siRNA against NRAGE (siNRG) transfection into TE13R120 cells. Compared with TE13 cells, an increasing number of TE13R120 cells with NRAGE overexpression in S phase and a lower ratio in G2/M were observed by flow cytometry method (FCM). Intriguingly, the above changes were partially reversed in TE13R120 cells treated with siNRG. More importantly, the ectopic subcellular localization of NRAGE mediated nuclear translocation of β-catenin which may be one reason of IR resistance of esophageal carcinoma cell. These data indicate that NRAGE extremely may be a pivotal factor involved in Wnt/β-catenin signal pathway, mediating nuclear translocation of β-catenin and then facilitating the formation of radioresistance of ESCC.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Weitere Produktempfehlungen anzeigen
Zusatzmaterial
High resolution image (TIF 1079 kb)
13277_2015_4747_MOESM1_ESM.tif
High resolution image (TIF 805 kb)
13277_2015_4747_MOESM2_ESM.tif
High resolution image (TIF 1660 kb)
13277_2015_4747_MOESM3_ESM.tif
High resolution image (TIF 1328 kb)
13277_2015_4747_MOESM4_ESM.tif
High resolution image (TIF 237 kb)
13277_2015_4747_MOESM5_ESM.tif
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 7/2016

Tumor Biology 7/2016 Zur Ausgabe
  1. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.